Skip to content

Preview

Over the past decade, sound policies, structural reform and strong growth have led to stark improvement among emerging markets (EM). When compared with the developed market (DM), it is evident that the gap in credit quality has narrowed. While DMs have seen a deterioration in their metrics since the COVID-19 pandemic, EMs have in most cases experienced superior growth rates, improving debt sustainability and strengthening fundamentals.

In this paper, we argue that the perceptions many investors have of EMs are typically neither accurate nor fair, especially for those investors less familiar with the asset class. In our analysis, EM fundamentals, in many cases, are superior to those of the DM world. Common preconceptions, which include riskiness, poor governance, high levels of corruption and unsustainable debt profiles, are inaccurate for most EMs.

Key considerations:

  • Fiscal: Is consolidation the path forward? The fiscal outlook for EMs appears more promising to us than that of DMs. This divergence is highlighted by key fiscal indicators such as interest payments relative to revenue, primary balances and debt to GDP, painting two deviating paths for these two asset classes.
  • Growth: The ever-important differential. A key strength of EMs has been the growth differential relative to DMs. Growth rates matter in the context of debt sustainability, as the higher the growth rate, the more expansionary fiscal policy can be without impacting debt levels. This means a country can run higher primary deficits without seeing debt-to-GDP grow. In other words, assuming zero primary deficits, a higher growth rate allows a country to outgrow its debt.

While investors are still justified in differentiating between DM and EM assets, EMs are improving to an extent that some now more closely resemble DM countries. The EM asset class is not a homogenous group, and any quantitative analysis should be combined with country-by-country fundamental analysis to fully understand the risks.



IMPORTANT LEGAL INFORMATION

Information on this website is intended to be of general information only and does not constitute investment or financial product advice. It expresses no views as to the suitability of the products or services described as to the individual circumstances, objectives, financial situation, or needs of any investor. You should conduct your own investigation or consult a financial adviser before making any decision to invest. Please read the relevant Product Disclosure Statements (PDSs), and any associated reference documents before making an investment decision.

Neither Franklin Templeton Australia, nor any other company within the Franklin Templeton group guarantees the performance of any Fund, nor do they provide any guarantee in respect of the repayment of your capital. In accordance with the Design and Distribution Obligations, we maintain Target Market Determinations (TMD) for each of our Funds. All documents can be found via the Literature Page or by calling 1800 673 776. 

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.